21 U.S.C. 396

From Conservapedia
This is the current revision of 21 U.S.C. 396 as edited by Aschlafly (Talk | contribs) at 19:52, December 21, 2022. This URL is a permanent link to this version of this page.

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

In 21 USCS § 396, federal law prohibits the FDA from interfering with the practice of medicine:

“ Nothing in this Act [21 USCS §§ 301 et seq.] shall be construed to limit or interfere with the authority of a health care practitioner to prescribe or administer any legally marketed device to a patient for any condition or disease within a legitimate health care practitioner-patient relationship. This section shall not limit any existing authority of the Secretary to establish and enforce restrictions on the sale or distribution, or in the labeling, of a device that are part of a determination of substantial equivalence, established as a condition of approval, or promulgated through regulations. Further, this section shall not change any existing prohibition on the promotion of unapproved uses of legally marketed devices. ”

21 U.S.C. § 396.

Retrieved from "https://conservapedia.com/index.php?title=21_U.S.C._396&oldid=1914852"